add site
services
publishers
database
health videos
toolbar
stats
live show
health store
more stuff
JOIN/LOGIN
| advertise add site services publishers database health videos
| | about toolbar stats live show health store more stuff JOIN/LOGIN |
| Health World US Business Political Technology Entertainment Sports Popular |
Prostate Treatment with Thermobalancing Therapy Free from Adverse Side Effects ...PR-Inside.com (Pressemitteilung) - Nov 29, 2009 2009-11-30 08:34:06 - Absolutely magnificent new Prostate treatment with Thermobalancing therapy is essential to use for cure BPH and Chronic Prostatitis. ... Chronic Prostatitis Treatment Free from Adverse Side Effects is Available Now ... PR.com (press release) Dissolve Kidney Stones Without Harmful Medications and Operation by Using ... PR-USA.net (press release) Treatment for BPH, Sciatica and Kidney Stones with Thermobalancing Therapy ... PR.com (press release) The role of nocturia in the quality of life of men with lower urinary tract ...UroToday - 4 hours ago Among the symptoms assessed using the International Prostate Symptom Score, nocturia (together with urgency and weak stream) had the strongest correlation ... Admin error forces GSK to withdraw Avodart prostate cancer sNDAPharma Times - - Nov 24, 2009 GlaxoSmithKline has withdrawn a supplemental New Drug Application in the USA for its benign prostatic hyperplasia treatment Avodart though the move is not ... Potential Drug for Prostate CancerGerson Lehrman Group - Nov 28, 2009 This drug has been in use already for the treatment of symptoms associated with Benign Prostatic Hypertrophy (BPH). There has been a lot of clinical ... Coexistence of pernicious anemia and prostate cancer - 'an experiment of ...7thSpace Interactive (press release) - Nov 24, 2009 IntroductionThis report presents the clinical and laboratory course of a patient with prostate cancer and severe vitamin B12 deficiency undergoing watchful ... Nymox's New Trial For Benign Prostatic Hyperplasia Drug Records Positive ...RTT News - Nov 23, 2009 ... US Phase 2 studies of NX-1207 indicated positive data from responder analysis, the new clinical trial for benign prostatic hyperplasia or BPH. ... Nymox Releases Positive New Clinical Trial Data on Durability of Benefits for ... CNNMoney.com (press release) Dendreon Reports Third Quarter 2009 Financial Results and Continuing Progress ...CNNMoney.com (press release) - Nov 11, 2009 PROVENGE is Dendreon's investigational product candidate for men with advanced prostate cancer and may represent the first in a new class of active cellular ... Finasteride and the Risk of Prostate CancerMedpie.com (blog) - - Nov 13, 2009 But some follow up studies and commentary were available, and the picture is not somewhat more nuanced: the Prostate Cancer Prevention Trial demonstrated ... Under the Radar Healthcare Stocks: Protox, Pressure BioSciences, UnilifeSeeking Alpha (blog) - - Nov 25, 2009 Urodynamix Technologies Ltd. Reports Fiscal 2009 Third Quarter ResultsBenzinga - 3 hours ago The Company is currently focused on products that aid in the diagnosis and treatment of urinary incontinence, lower urinary tract symptoms, prostate cancer, ... | How to call the show... 1) Make sure the show is live (see graphic above). 2) Dial 724-444-7444. 3) Enter Call ID# 27566 when prompted. 4) Follow the phone prompts to join the call. Would you like to be a special guest on the show? Send us an email which includes your contact information and the topic(s) that you would like to discuss. Listen to past shows featuring special guests...  Bernard von NotHaus (Liberty Dollar)Aubrey de Grey, PhDDr. Amanuel Sima, MDDr. Bard Levey, DDSNeal AdamsRobin Scovill (director)Richard Diaz (author)Dr. Kaayla T. Daniel, CCNChana de Wolf, (cryonics researcher)Dr. Mary Ruwart (author & scientist)Richard Diaz (author)Dr. Jason Helliwell, OB/GYN |
| ↑ top of page ↑ | about thumbshots |
